CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

Currently sporting a Zacks Rank #1 (Strong Buy), OMCL stock has delivered an impressive performance in the past year. Shares of the company have risen 39.4% against the industry's 4.2% fall and the ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent — for billions in profits, according to a report from the Federal Trade ...

The Manufacturing Pharmacy segment manufactures and sells generic and clinic drugs, such as traditional anti-inflammatory and antibacterial drugs, cancer treatment drugs, cardio-vascular disease ...